DARPA selects Autonomous Therapeutics to support PREventing EMerging Pathogenic Threats (PREEMPT) initiative

“DARPA has selected five teams of researchers to support PREventing EMerging Pathogenic Threats (PREEMPT), a 3.5-year program first announced in January 2018 to reinforce traditional medical preparedness by containing viral infectious diseases in animal reservoirs and insect vectors before they can threaten humans.”

Previous
Previous

Autonomous Therapeutics selected for BLUE KNIGHT, a joint initiative between BARDA (a component of the U.S. Department of Health and Human Services) and Johnson & Johnson Innovation – JLABS